ISSN: 1523-3847

Journal Guideline

Current Infectious Disease Reports Q1 Unclaimed

Current Science, Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Infectious Disease Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of infectious disease. Offers the views of experts on current advances in the infectious disease field Highlights the most important recent papers from a wealth of original publications Also provides supplementary reviews featuring recently published clinical trials, valuable web sites, and commentaries from well-known figures in the field It has an SJR impact factor of 0,969.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Infectious Diseases (Q1)

Price

3060 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,969

SJR Impact factor

60

H Index

32

Total Docs (Last Year)

80

Total Docs (3 years)

2184

Total Refs

292

Total Cites (3 years)

80

Citable Docs (3 years)

3.54

Cites/Doc (2 years)

68.25

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Reviews Microbiology Q1
Clinical Microbiology Reviews Q1
The Lancet Infectious Diseases Q1
Cellular and Molecular Immunology Q1
Drug Resistance Updates Q1

Compare this journals

Aims and Scope

Best articles by citations

Impact of antimicrobial resistance on the treatment of invasive pneumococcal infections

Management of antiretroviral therapy in neonates, children, and adolescents

The Importance of Colonization with Clostridium difficile on Infection and Transmission

Health Care-Associated Infective Endocarditis: a Growing Entity that Can Be Prevented

African trypanosomiasis: Changing epidemiology and consequences

Does lactobacillus prevent post-antibiotic vulvovaginal candidiasis?

New insights on interactions between HIV-1 and HSV-2

Pharmacologic aspects of new antiretroviral drugs

Inflammatory Markers Associated with Coronary Heart Disease in Persons with HIV Infection

Estrogen replacement therapy to prevent recurrent urinary tract infection in postmenopausal women

New biomedical strategies for HIV-1 prevention in women

New fluoroquinolones: Real and potential roles

SHOW MORE ARTICLES

Immune restoration inflammatory syndromes: The dark side of successful antiretroviral treatment

Health Considerations for HIV-Infected International Travelers

What Is New in Antibiotic Therapy in Community-Acquired Pneumonia? An Evidence-Based Approach Focusing on Combined Therapy

Management of HIV infection in patients with substance use problems

Mucormycosis of the Head and Neck

When to Start Antiretroviral Therapy

HIV, Sexually Transmitted Infections, and Sexuality in Later Life

Optimal management of uncomplicated skin and skin structure infections of the lower extremity

Duration of antibiotic treatment for urinary tract infection

Azithromycin versus penicillin in acute group A streptococcal tonsillopharyngitis

Adjunctive therapies in severe sepsis and septic shock: Current place of steroids

Azole Antifungal Resistance Today: Focus on Aspergillus